Google Ads Expands Melatonin Advertising Beyond US and Canada Starting June 2025
Policy Update on Melatonin Advertising
In June 2025, Google Ads will revise its Healthcare and Medicines policy to remove restrictions on promoting melatonin products outside the United States and Canada. Previously, melatonin advertising was only permitted within these two countries.
Key Details of the Change
- Promotion of melatonin products will be allowed globally, subject to local laws and regulations.
- The updated policy removes the prohibition under the Unapproved Substances section.
- Advertisers will receive a warning at least 7 days before any account suspension related to policy violations, rather than immediate suspension.
Implications for Advertisers
This change opens new advertising opportunities for companies selling melatonin products internationally, enabling more flexible marketing strategies compliant with local regulations.
Source: Search Engine Roundtable by barry@rustybrick.com (Barry Schwartz). Read original.
